These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 8678101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
    Holloway WJ, Palmer D.
    Am J Med; 1996 Jun 24; 100(6A):52S-59S. PubMed ID: 8678098
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cefepine vs. ceftazidime treatment of pyelonephritis: a European, randomized, controlled study of 300 pediatric cases. European Society for Paediatric Infectious Diseases (ESPID) Pyelonephritis Study Group.
    Schaad UB, Eskola J, Kafetzis D, Fishbach M, Ashkenazi S, Syriopoulou V, Boulesteix J, De Pril V, Grès JJ, Rollin C.
    Pediatr Infect Dis J; 1998 Jul 24; 17(7):639-44. PubMed ID: 9686732
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial.
    Bradley JS, Roilides E, Broadhurst H, Cheng K, Huang LM, MasCasullo V, Newell P, Stone GG, Tawadrous M, Wajsbrot D, Yates K, Gardner A.
    Pediatr Infect Dis J; 2019 Sep 24; 38(9):920-928. PubMed ID: 31335570
    [Abstract] [Full Text] [Related]

  • 13. Cefepime: a review of its use in the management of hospitalized patients with pneumonia.
    Chapman TM, Perry CM.
    Am J Respir Med; 2003 Sep 24; 2(1):75-107. PubMed ID: 14720024
    [Abstract] [Full Text] [Related]

  • 14. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
    Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, Moreau P, Ladeb S, Nalet V, Rollin C, Gres JJ.
    Clin Infect Dis; 1997 Jan 24; 24(1):41-51. PubMed ID: 8994754
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: in comparison with ceftazidime treatment.
    Chang SC, Fang CT, Hsueh PR, Liu CJ, Sheng WH, Hsieh SM, Hung CC, Chen YC.
    Int J Antimicrob Agents; 1998 Aug 24; 10(3):245-8. PubMed ID: 9832286
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample.
    Pfaller MA, Marshall SA, Jones RN.
    Diagn Microbiol Infect Dis; 1997 Dec 24; 29(4):273-6. PubMed ID: 9458985
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients.
    Wang FD, Liu CY, Hsu HC, Gau JP, Chau WK, Haung ML, Ho CH.
    Chemotherapy; 1999 Dec 24; 45(5):370-9. PubMed ID: 10473925
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infections.
    Léophonte P, Bertrand A, Nouvet G, Muir JF, Lucht F, Delaval P, Depierre A, Hughes F, Ulmer M, Grès JJ.
    J Antimicrob Chemother; 1993 Nov 24; 32 Suppl B():165-73. PubMed ID: 8150760
    [Abstract] [Full Text] [Related]

  • 19. Cefepime versus ceftazidime in the treatment of lower respiratory tract infections.
    Aufiero A, Sturani C, Zanon P, Marruchella A, Michetti G, Nicolin E, Sella D, Goglio A, Silleni M, La Regina A.
    J Chemother; 1997 Jun 24; 9(3):213-8. PubMed ID: 9210005
    [Abstract] [Full Text] [Related]

  • 20. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.
    Carmeli Y, Armstrong J, Laud PJ, Newell P, Stone G, Wardman A, Gasink LB.
    Lancet Infect Dis; 2016 Jun 24; 16(6):661-673. PubMed ID: 27107460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.